Press "Enter" to skip to content

New patent for Ascend Theraps drug BINOSTO

1
Copyright © DrugPatentWatch. Originally published at New patent for Ascend Theraps drug BINOSTO

Annual Drug Patent Expirations for BINOSTO
Annual Drug Patent Expirations for BINOSTO

Binosto is a drug marketed by Ascend Theraps Us and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

BINOSTO drug price trends.

This drug has ten patent family members in seven countries.

The generic ingredient in BINOSTO is alendronate sodium. One supplier is listed for this compound. Additional details are available on the alendronate sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Ascend Theraps drug BINOSTO

Comments are closed.

Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions